TipRanks on MSN
Eli Lilly’s new study on LY4213663: A potential game-changer for rheumatoid arthritis?
Eli Lilly And Company ($LLY) announced an update on their ongoing clinical study. Eli Lilly and Company is conducting a Phase ...
Orforglipron helped keep weight down when used after initial therapy with an injectable, a new treatment strategy that could ...
In an added benefit, more than one in eight people taking the highest dose of Retratrutide were completely free of arthritic ...
Eli Lilly (NYSE:LLY) shares rose about 2% on early Thursday after the company said a pivotal study for its experimental ...
Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.
Seeking Alpha's roundup of statements, announcements, and remarks that could impact markets, sectors, or individual stocks.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results